Blavatnik Len's Form 4 filing
Upstream Bio, Inc.UPB · filed Oct 17, 2024
- Accession no.
- 0000950170-24-115295
- Filed
- Oct 17, 2024, 4:05 PM ET
- Trade date
- Oct 15, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $20.0M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Blavatnik LenCIK 0001326628 | 10% Owner |
| Access Industries Holdings LLCCIK 0001391297 | 10% Owner |
| Access Industries Management, LLCCIK 0001508226 | 10% Owner |
| AI Biotechnology LLCCIK 0001942670 | 10% Owner |
| AI Upstream LLCCIK 0002039907 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Common Stock | PPurchaseAcquired | +1,175,000 | $17.00 | +$19,975,000 | 1,175,000 | Direct | |
| Oct 15, 2024 | Common Stock | CConversionAcquired | +3,147,000 | –F1 | – | 4,322,000 | Direct | |
| Oct 15, 2024 | Common Stock | CConversionAcquired | +1,172,410 | –F1 | – | 5,494,410 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of the Issuer's Series A preferred stock and Series B preferred stock (collectively, the "Preferred Stock") converted into Common Stock on a 1.049-for-one basis upon closing of the Issuer's initial public offering without payment of consideration. The Preferred Stock had no expiration date.
Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.